Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Peak Bio, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/15/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
| 08/14/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 08/11/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/10/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/10/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/03/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/24/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/21/2023 |
8-K
| Quarterly results |
| 07/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/01/2023 |
8-K
| Quarterly results |
| 04/21/2023 |
8-K
| Quarterly results |
| 03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 03/21/2023 |
SC 13D
| Huh Hoyoung reports a 40.2% stake in Peak Bio, Inc. |
| 03/17/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 03/17/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office... |
| 03/09/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 03/03/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/02/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/28/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2023 |
SC 13G/A
| Vellar Opportunities Fund Master, Ltd. reports a 0% stake in IGNYTE ACQUISITION CORP. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 1.8% stake in Peak Bio, Inc. |
| 02/03/2023 |
SC 13G/A
| FROST PHILLIP MD ET AL reports a 1.6% stake in §240.13d-2 PEAK BIO, INC. |
| 01/09/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 01/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Form of PIPE Subscription Agreement, by and between Peak Bio, Inc. and the Investor party thereto",
"Form of Amendment to Lock-Up Agreement",
"Amendment to Key Company Stockholder Forward Purchase Agreement, by and between Peak Bio, Inc. and Hoyoung Huh",
"Unaudited pro forma condensed combined financial information of the Company and the related notes thereto as of and for the nine months ended September 30, 2022 and for the year ended December 31, 2021" |
|
| 11/21/2022 |
8-K/A
| Other Events, Financial Statements and Exhibits Interactive Data |
| 11/21/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/07/2022 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...|
Docs:
|
"Second Amended and Restated Certificate of Incorporation of Peak Bio, Inc",
"Amended and Restated Bylaws of Peak Bio, Inc",
"Registration Rights Agreement, by and among Peak Bio, Inc., Ignyte Sponsor LLC and the Holders party thereto",
"Lock-Up Agreement",
"Key Company Stockholder Lock-Up Agreement",
"Cover Page Interactive Data File (formatted as Inline XBRL)",
"Common Stock Purchase Agreement, by and between White Lion Capital, LLC and Peak Bio, Inc",
"Registration Rights Agreement, by and between White Lion Capital, LLC and Peak Bio, Inc",
"Unaudited Carve-out Condensed Consolidated financial statements of Peak Bio Co., Ltd and the related notes thereto as of and for the six months ended June 30, 2022 and 2021",
"Unaudited Condensed Consolidated financial statements of Ignyte Acquisition Corp. and the related notes thereto as of and for the six months ended June 30, 2022 and 2021" |
|
| 10/28/2022 |
8-K/A
| Quarterly results |
| 10/27/2022 |
8-K
| Quarterly results |
| 10/24/2022 |
8-K
| Quarterly results |
| 10/18/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 10/18/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/18/2022 |
8-K
| Other Events Interactive Data |
|
|
|